In the news
Cost-benefit analysis set for Advate, hemophilia A treatment
December 21, 2020Hemophilia News Today
Related news
In the news
July 12, 2024
Study Shows 85% Of Patients Discontinue GLP-1s For Weight Loss After 2 Years
Forbes
In the news
July 11, 2024
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
U.S. News & World Report